Investigational Drug Information for IW-1973
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for IW-1973?
IW-1973 is an investigational drug.
There have been 7 clinical trials for IW-1973.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Hypertension. The leading clinical trial sponsors are Cyclerion Therapeutics, Ironwood Pharmaceuticals, Inc., and [disabled in preview].
There are four US patents protecting this investigational drug and fifty-nine international patents.
Summary for IW-1973
| US Patents | 4 |
| International Patents | 59 |
| US Patent Applications | 43 |
| WIPO Patent Applications | 27 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 2 (2016-09-01) |
| Vendors | 12 |
Recent Clinical Trials for IW-1973
| Title | Sponsor | Phase |
|---|---|---|
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers | Cyclerion Therapeutics | Phase 1 |
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers | Ironwood Pharmaceuticals, Inc. | Phase 1 |
| A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers | Cyclerion Therapeutics | Phase 1 |
Clinical Trial Summary for IW-1973
Top disease conditions for IW-1973
Top clinical trial sponsors for IW-1973
US Patents for IW-1973
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| IW-1973 | See Plans and Pricing | sGC stimulators | Ironwood Pharmaceuticals, Inc. (Cambridge, MA) | See Plans and Pricing |
| IW-1973 | See Plans and Pricing | sGC stimulators | Cyclerion Therapeutics, Inc. (Cambridge, MA) | See Plans and Pricing |
| IW-1973 | See Plans and Pricing | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | See Plans and Pricing |
| IW-1973 | See Plans and Pricing | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for IW-1973
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| IW-1973 | Australia | AU2014227862 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | Australia | AU2019203606 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | Australia | AU2021204292 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | Brazil | BR112015023349 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | Canada | CA2907111 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | China | CN105408328 | 2033-03-15 | See Plans and Pricing |
| IW-1973 | China | CN108912111 | 2033-03-15 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
